恩威医药(301331.SZ)：股东拟询价转让3.89%股份
Enwei PharmaceuticalEnwei Pharmaceutical(SZ:301331) Ge Long Hui A P P·2026-01-26 13:30

Group 1 - The core point of the article is that Enwei Pharmaceutical (301331.SZ) is planning to participate in the pre-IPO share transfer, with Chengdu Enwei Investment (Group) Co., Ltd. as the selling shareholder [1] - The total share capital of the company is 102,891,887 shares, with 1,055,326 shares held in the company's repurchase special securities account [1] - The selling shareholder intends to transfer a total of 4,000,000 shares, which represents 3.89% of the company's total share capital and 3.93% of the total share capital excluding the repurchased shares [1]

Enwei Pharmaceutical-恩威医药(301331.SZ)：股东拟询价转让3.89%股份 - Reportify